{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:12:58Z","timestamp":1754154778174,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,24]]},"DOI":"10.7759\/cureus.88683","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T18:35:56Z","timestamp":1753382156000},"source":"Crossref","is-referenced-by-count":0,"title":["Oral Cephalosporin-Induced Anaphylaxis Presenting With Severe Tachycardia: A Case of Microdosed Epinephrine Over Standard Protocols"],"prefix":"10.7759","author":[{"given":"Anupama","family":"R S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan Krishna","family":"NK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathya Lakshmi","family":"Mekkoth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Sridhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaraj","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2021.09.010","article-title":"Anaphylaxis: Epidemiology and differential diagnosis","volume":"42","author":"Motosue MS","year":"2022","unstructured":"Motosue MS, Li JT, Campbell RL. Anaphylaxis: Epidemiology and differential diagnosis. Immunol Allergy Clin North Am. 2022, 42:13-25. 10.1016\/j.iac.2021.09.010","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref2","article-title":"Anaphylaxis","author":"McLendon K","year":"2025","unstructured":"McLendon K, Sternard BT. Anaphylaxis. StatPearls [Internet], Treasure Island, FL; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: Summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson HA","year":"2006","unstructured":"Sampson HA, Mu\u00f1oz-Furlong A, Campbell RL, et al.. Second symposium on the definition and management of anaphylaxis: Summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006, 117:391-7. 10.1016\/j.jaci.2005.12.1303","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/all.13207","article-title":"Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis","volume":"72","author":"Oropeza AR","year":"2017","unstructured":"Oropeza AR, Bindslev-Jensen C, Broesby-Olsen S, et al.. Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis. Allergy. 2017, 72:1944-52. 10.1111\/all.13207","journal-title":"Allergy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2023.1249280","article-title":"Population-based incidence of all-cause anaphylaxis and its development over time: A systematic review and meta-analysis","volume":"4","author":"P\u00fchringer V","year":"2023","unstructured":"P\u00fchringer V, Jilma B, Herkner H. Population-based incidence of all-cause anaphylaxis and its development over time: A systematic review and meta-analysis. Front Allergy. 2023, 4:1249280. 10.3389\/falgy.2023.1249280","journal-title":"Front Allergy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192416716","article-title":"Idiopathic anaphylaxis? Analysis of data from the Anaphylaxis Registry for West Pomerania Province, Poland","volume":"19","author":"Poziomkowska-G\u0119sicka I","year":"2022","unstructured":"Poziomkowska-G\u0119sicka I. Idiopathic anaphylaxis? Analysis of data from the Anaphylaxis Registry for West Pomerania Province, Poland. Int J Environ Res Public Health. 2022, 19:16716. 10.3390\/ijerph192416716","journal-title":"Int J Environ Res Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845689","article-title":"A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)","volume":"13","author":"Li X","year":"2022","unstructured":"Li X, Ma Q, Yin J, et al.. A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020). Front Pharmacol. 2022, 13:845689. 10.3389\/fphar.2022.845689","journal-title":"Front Pharmacol"},{"key":"ref8","article-title":"Epinephrine","author":"Dalal R","year":"2025","unstructured":"Dalal R, Grujic D. Epinephrine. StatPearls [Internet], Treasure Island, FL; 2025."},{"key":"ref9","article-title":"Managing acute anaphylaxis. Intravenous adrenaline should be considered because of the urgency of the condition","volume":"320","author":"Sadana A","year":"2000","unstructured":"Sadana A, O'Donnell C, Hunt MT, Gavalas M. Managing acute anaphylaxis. Intravenous adrenaline should be considered because of the urgency of the condition. BMJ. 2000, 320:937.","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03528-y","article-title":"An unusual presentation of anaphylaxis with severe hypertension: A case report","volume":"16","author":"Govindapala D","year":"2022","unstructured":"Govindapala D, Senarath US, Wijewardena D, Nakkawita D, Undugodage C. An unusual presentation of anaphylaxis with severe hypertension: A case report. J Med Case Rep. 2022, 16:327. 10.1186\/s13256-022-03528-y","journal-title":"J Med Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63987","article-title":"A rare case of cephalosporin anaphylaxis-induced reverse takotsubo","volume":"16","author":"Farooq O","year":"2024","unstructured":"Farooq O, Lin R, Easow B, Chhabra P, Kaur P. A rare case of cephalosporin anaphylaxis-induced reverse takotsubo. Cureus. 2024, 16:e63987. 10.7759\/cureus.63987","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-009-9083-0","article-title":"Stress-induced cardiomyopathy following cephalosporin-induced anaphylactic shock during general anesthesia","volume":"56","author":"Suk EH","year":"2009","unstructured":"Suk EH, Kim DH, Kweon TD, Na SW, Shin JA. Stress-induced cardiomyopathy following cephalosporin-induced anaphylactic shock during general anesthesia. Can J Anaesth. 2009, 56:432-6. 10.1007\/s12630-009-9083-0","journal-title":"Can J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40981-022-00581-w","article-title":"Intraoperative chlorhexidine-induced anaphylaxis suggesting an immunoglobulin-E-dependent mechanism indicated by basophil activation tests: Two case reports","volume":"8","author":"Orihara M","year":"2022","unstructured":"Orihara M, Takazawa T, Horiuchi T, Nagumo K, Maruyama N, Tomioka A, Saito S. Intraoperative chlorhexidine-induced anaphylaxis suggesting an immunoglobulin-E-dependent mechanism indicated by basophil activation tests: Two case reports. JA Clin Rep. 2022, 8:91. 10.1186\/s40981-022-00581-w","journal-title":"JA Clin Rep"},{"key":"ref14","unstructured":"CDC. Managing Anaphylaxis at COVID-19 Vaccination Sites. (2021). Accessed. March 31, 2025:  https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/managing-anaphylaxis.html ."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.306","article-title":"Current update on anaphylaxis: anaphylaxis management in recent guidelines","volume":"56","author":"Antol\u00edn-Am\u00e9rigo D","year":"2024","unstructured":"Antol\u00edn-Am\u00e9rigo D, Vidal-Albareda C, Gonz\u00e1lez de Olano D, de la Hoz-Caballer B. Current update on anaphylaxis: anaphylaxis management in recent guidelines. Eur Ann Allergy Clin Immunol. 2024, 56:51-64. 10.23822\/EurAnnACI.1764-1489.306","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15441\/ceem.23.129","article-title":"Inappropriate use of intravenous epinephrine leading to atrial fibrillation during prehospital anaphylaxis treatment: A case report","volume":"11","author":"Jung H","year":"2024","unstructured":"Jung H, Ryoo HW, Park J, Choi SH, Lee JH, Kim S. Inappropriate use of intravenous epinephrine leading to atrial fibrillation during prehospital anaphylaxis treatment: A case report. Clin Exp Emerg Med. 2024, 11:304-8. 10.15441\/ceem.23.129","journal-title":"Clin Exp Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2022-0073","article-title":"Emergency treatment of anaphylaxis: Concise clinical guidance","volume":"22","author":"Whyte AF","year":"2022","unstructured":"Whyte AF, Soar J, Dodd A, Hughes A, Sargant N, Turner PJ. Emergency treatment of anaphylaxis: Concise clinical guidance. Clin Med (Lond). 2022, 22:332-9. 10.7861\/clinmed.2022-0073","journal-title":"Clin Med (Lond)"},{"key":"ref18","unstructured":"U.S. Food and Drug Administration. FDA approves first nasal spray for treatment of severe allergic reactions, including anaphylaxis. (2024). Accessed. May 18, 2025: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-nasal-spray-treatment-anaphylaxis."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.09.05","article-title":"Anaphylactic cardiovascular collapse and Kounis syndrome: Systemic vasodilation or coronary vasoconstriction?","volume":"6","author":"Kounis NG","year":"2018","unstructured":"Kounis NG, Cervellin G, Koniari I, et al.. Anaphylactic cardiovascular collapse and Kounis syndrome: Systemic vasodilation or coronary vasoconstriction?. Ann Transl Med. 2018, 6:332. 10.21037\/atm.2018.09.05","journal-title":"Ann Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona V","year":"2020","unstructured":"Cardona V, Ansotegui IJ, Ebisawa M, et al.. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020, 13:100472. 10.1016\/j.waojou.2020.100472","journal-title":"World Allergy Organ J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/380424-oral-cephalosporin-induced-anaphylaxis-presenting-with-severe-tachycardia-a-case-of-microdosed-epinephrine-over-standard-protocols","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T18:35:58Z","timestamp":1753382158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/380424-oral-cephalosporin-induced-anaphylaxis-presenting-with-severe-tachycardia-a-case-of-microdosed-epinephrine-over-standard-protocols"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.88683","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}